Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide / Carla M. Canuso en The American Journal of Psychiatry, Año 2018 - Vol. 175 - No. 7 (Julio)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 7 (Julio) . - pp. 620-630 Título : Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide : Results of a Double-Blind, Randomized, Placebo-Controlled Study Tipo de documento: texto impreso Autores: Carla M. Canuso, Autor ; Jaskaran B. Singh, Autor ; Maggie Fedgchin, Autor Fecha de publicación: 2018 Artículo en la página: pp. 620-630 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Depresión, Esketamina, Antidepresivo rápido, Suicidio Resumen: The authors compared the efficacy of standard-of-care treatment plus intranasal esketamine or placebo for rapid reduction of symptoms of major depression, including suicidality, among individuals at imminent suicide risk. Link: ./index.php?lvl=notice_display&id=17654 [artículo] Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide : Results of a Double-Blind, Randomized, Placebo-Controlled Study [texto impreso] / Carla M. Canuso, Autor ; Jaskaran B. Singh, Autor ; Maggie Fedgchin, Autor . - 2018 . - pp. 620-630. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2018 - Vol. 175 - No. 7 (Julio) . - pp. 620-630 Etiquetas: Depresión, Esketamina, Antidepresivo rápido, Suicidio Resumen: The authors compared the efficacy of standard-of-care treatment plus intranasal esketamine or placebo for rapid reduction of symptoms of major depression, including suicidality, among individuals at imminent suicide risk. Link: ./index.php?lvl=notice_display&id=17654

---

1 (1 - 1 / 1)